本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

0.3804
-0.0266-6.54%
盘后0.38820.0078+2.05%19:56 EDT
成交量:250.10万
成交额:99.73万
市值:4,740.98万
市盈率:-0.63
高:0.4295
开:0.4200
低:0.3785
收:0.4070
数据加载中...
2021/08/06

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/05/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/04/09

重要事件披露

8-K - Current report
2021/03/11

重要事件披露

8-K - Current report
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/26

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/05

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership